{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:04:47Z","timestamp":1791104687012,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.cca.2006.06.020","type":"journal-article","created":{"date-parts":[[2006,6,23]],"date-time":"2006-06-23T09:27:43Z","timestamp":1151054863000},"page":"87-91","source":"Crossref","is-referenced-by-count":33,"title":["The variation of the sarcolipin gene (SLN) in atrial fibrillation, long QT syndrome and sudden arrhythmic death syndrome"],"prefix":"10.1016","volume":"375","author":[{"given":"Mia Titine","family":"Nyberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte","family":"Stoevring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elijah Raphael","family":"Behr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse Steen","family":"Ravn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2006.06.020_bib1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation\u2013contraction coupling","volume":"415","author":"Bers","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cca.2006.06.020_bib2","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1161\/01.CIR.0000132472.98675.EC","article-title":"Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak","volume":"109","author":"Lehnart","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2006.06.020_bib3","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/01.CIR.103.2.196","article-title":"Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia","volume":"103","author":"Priori","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2006.06.020_bib4","doi-asserted-by":"crossref","first-page":"11759","DOI":"10.1073\/pnas.1932318100","article-title":"Calsequestrin determines the functional size and stability of cardiac intracellular calcium stores: mechanisms for hereditary arrhythmia","volume":"100","author":"Terentyev","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cca.2006.06.020_bib5","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1086\/324565","article-title":"A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel","volume":"69","author":"Lahat","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cca.2006.06.020_bib6","doi-asserted-by":"crossref","first-page":"8089","DOI":"10.1073\/pnas.0502506102","article-title":"Severe arrhythmia disorder caused by L-type calcium channel mutations","volume":"102","author":"Splawski","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cca.2006.06.020_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cell.2004.09.011","article-title":"Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism","volume":"119","author":"Splawski","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.cca.2006.06.020_bib8","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1749-6632.2003.tb07231.x","article-title":"The regulation of SERCA-type pumps by phospholamban and sarcolipin","volume":"986","author":"MacLennan","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cca.2006.06.020_bib9","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1073\/pnas.0510519103","article-title":"A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy","volume":"103","author":"Haghighi","year":"2006","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cca.2006.06.020_bib10","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/0003-9861(92)90457-8","article-title":"Sarcolipin, the \u201cproteolipid\u201d of skeletal muscle sarcoplasmic reticulum, is a unique, amphipathic, 31-residue peptide","volume":"298","author":"Wawrzynow","year":"1992","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.cca.2006.06.020_bib11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1006\/geno.1997.4967","article-title":"Characterization of the gene encoding human sarcolipin (SLN), a proteolipid associated with SERCA1: absence of structural mutations in five patients with Brody disease","volume":"45","author":"Odermatt","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.cca.2006.06.020_bib12","doi-asserted-by":"crossref","first-page":"9570","DOI":"10.1074\/jbc.M213132200","article-title":"Atrial chamber-specific expression of sarcolipin is regulated during development and hypertrophic remodeling","volume":"278","author":"Minamisawa","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2006.06.020_bib13","doi-asserted-by":"crossref","first-page":"26725","DOI":"10.1074\/jbc.C200269200","article-title":"Sarcolipin inhibits polymerization of phospholamban to induce superinhibition of sarco(endo)plasmic reticulum Ca2+-ATPases (SERCAs)","volume":"277","author":"Asahi","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2006.06.020_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/01.RES.75.3.401","article-title":"Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation","volume":"75","author":"Luo","year":"1994","journal-title":"Circ Res"},{"key":"10.1016\/j.cca.2006.06.020_bib15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1172\/JCI118446","article-title":"Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice","volume":"97","author":"Kadambi","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2006.06.020_bib16","doi-asserted-by":"crossref","first-page":"10538","DOI":"10.1074\/jbc.275.14.10538","article-title":"Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo","volume":"275","author":"Zhai","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2006.06.020_bib17","doi-asserted-by":"crossref","first-page":"14985","DOI":"10.1074\/jbc.275.20.14985","article-title":"The transgenic expression of highly inhibitory monomeric forms of phospholamban in mouse heart impairs cardiac contractility","volume":"275","author":"Zvaritch","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2006.06.020_bib18","doi-asserted-by":"crossref","first-page":"24145","DOI":"10.1074\/jbc.M102403200","article-title":"Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure","volume":"276","author":"Haghighi","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2006.06.020_bib19","doi-asserted-by":"crossref","first-page":"9199","DOI":"10.1073\/pnas.0402596101","article-title":"Cardiac-specific overexpression of sarcolipin inhibits sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA2a) activity and impairs cardiac function in mice","volume":"101","author":"Asahi","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cca.2006.06.020_bib20","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.bbrc.2005.06.186","article-title":"Mechanical stress-dependent transcriptional regulation of sarcolipin gene in the rodent atrium","volume":"334","author":"Shimura","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cca.2006.06.020_bib21","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.febslet.2006.03.032","article-title":"Post-transcriptional downregulation of sarcolipin mRNA by triiodothyronine in the atrial myocardium","volume":"580","author":"Minamisawa","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.cca.2006.06.020_bib22","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1365-2362.2004.01422.x","article-title":"Down-regulation of sarcolipin mRNA expression in chronic atrial fibrillation","volume":"34","author":"Uemura","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cca.2006.06.020_bib23","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0140-6736(03)14692-2","article-title":"Sudden arrhythmia death syndrome steering group. Cardiological assessment of first-degree relatives in sudden death arrhythmic death syndrome","volume":"362","author":"Behr","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2006.06.020_bib24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.amjcard.2005.03.086","article-title":"Relation between the 97T polymorphism in KCNE5 and risk of atrial fibrillation","volume":"96","author":"Ravn","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cca.2006.06.020_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/14017430410028645","article-title":"Prolonged signal-averaged P wave duration after elective cardioversion increases the risk of recurrent atrial fibrillation","volume":"38","author":"Dixen","year":"2004","journal-title":"Scand Cardiovasc J"},{"key":"10.1016\/j.cca.2006.06.020_bib26","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1101\/gr.849004","article-title":"WebLogo: a sequence logo generator","volume":"14","author":"Crooks","year":"2004","journal-title":"Genome Res"},{"key":"10.1016\/j.cca.2006.06.020_bib27","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.2337\/diabetes.50.8.1952","article-title":"A cluster of three single nucleotide polymorphisms in the 3\u2032-untranslated region of human glycoprotein PC-1 gene stabilizes PC-1 mRNA and is associated with increased PC-1 protein content and insulin resistance-related abnormalities","volume":"50","author":"Frittita","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2006.06.020_bib28","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.2337\/diabetes.51.12.3554","article-title":"FOXC2 mRNA expression and a 5\u2032untranslated region polymorphism of the gene are associated with insulin resistance","volume":"51","author":"Ridderstrale","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2006.06.020_bib29","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1086\/339270","article-title":"A variation in 3\u2032UTR of hPTP1B increases specific gene expression and associates with insulin resistance","volume":"70","author":"Paola","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cca.2006.06.020_bib30","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1146\/annurev.cellbio.14.1.399","article-title":"Control of translation initiation in animals","volume":"14","author":"Gray","year":"1998","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.cca.2006.06.020_bib31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1023\/A:1011982932645","article-title":"The role of 3\u2032-untranslated region (3\u2032-UTR) mediated mRNA stability in cardiovascular pathophysiology","volume":"224","author":"Misquitta","year":"2001","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.cca.2006.06.020_bib32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1677\/joe.0.1570361","article-title":"Post-transcriptional gene regulatory mechanisms in eukaryotes: an overview","volume":"157","author":"Day","year":"1998","journal-title":"J Endocrinol"},{"key":"10.1016\/j.cca.2006.06.020_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-291X(03)00526-6","article-title":"Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy","volume":"304","author":"Minamisawa","year":"2003","journal-title":"Biochim Biophys Res Commun"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898106003901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898106003901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T09:25:37Z","timestamp":1547544337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898106003901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":33,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0009898106003901"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2006.06.020","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}